Literature DB >> 3686281

The problem of compliance in rheumatic fever.

K G Walker1, D G Human, M M De Moor, K J Sprenger.   

Abstract

During a 12-month period 115 patients defaulted from a rheumatic fever clinic, so a study was undertaken to identify factors related to non-compliance by comparing defaulters with a group of 50 regular attenders. Those defaulting were significantly more likely to be coloured, male, and over 12 years old. They lived 10-99 km from the hospital, were on several drugs and despite more frequent appointments, usually had a record of poor attendance. The severity of the underlying heart disease and use of parenteral penicillin did not affect compliance. Since the use of regular penicillin prophylaxis for the secondary prevention of rheumatic fever is an essential step in reducing the prevalence of rheumatic heart disease, rheumatic fever clinics should be structured to address the needs of adolescents. Furthermore, the use of neighbourhood clinics for routine therapy between visits to a rheumatic fever clinic is essential to improve compliance.

Entities:  

Mesh:

Year:  1987        PMID: 3686281

Source DB:  PubMed          Journal:  S Afr Med J


  7 in total

1.  Response to Godown and Beaton-Handheld echocardiography: A new tool for rheumatic heart disease in the developing world?

Authors:  Marc G W Rémond; Graeme P Maguire
Journal:  Transl Pediatr       Date:  2015-07

2.  Characteristics, complications, and gaps in evidence-based interventions in rheumatic heart disease: the Global Rheumatic Heart Disease Registry (the REMEDY study).

Authors:  Liesl Zühlke; Mark E Engel; Ganesan Karthikeyan; Sumathy Rangarajan; Pam Mackie; Blanche Cupido; Katya Mauff; Shofiqul Islam; Alexia Joachim; Rezeen Daniels; Veronica Francis; Stephen Ogendo; Bernard Gitura; Charles Mondo; Emmy Okello; Peter Lwabi; Mohammed M Al-Kebsi; Christopher Hugo-Hamman; Sahar S Sheta; Abraham Haileamlak; Wandimu Daniel; Dejuma Y Goshu; Senbeta G Abdissa; Araya G Desta; Bekele A Shasho; Dufera M Begna; Ahmed ElSayed; Ahmed S Ibrahim; John Musuku; Fidelia Bode-Thomas; Basil N Okeahialam; Olukemi Ige; Christopher Sutton; Rajeev Misra; Azza Abul Fadl; Neil Kennedy; Albertino Damasceno; Mahmoud Sani; Okechukwu S Ogah; Taiwo Olunuga; Huda H M Elhassan; Ana Olga Mocumbi; Abiodun M Adeoye; Phindile Mntla; Dike Ojji; Joseph Mucumbitsi; Koon Teo; Salim Yusuf; Bongani M Mayosi
Journal:  Eur Heart J       Date:  2014-11-25       Impact factor: 29.983

3.  No demonstrable effect of benzathine penicillin on recurrence of rheumatic Fever in pacific island population.

Authors:  Michael D Seckeler; Tracey R Hoke; Matthew J Gurka; Leslie L Barton
Journal:  Pediatr Cardiol       Date:  2010-04-22       Impact factor: 1.655

4.  Preliminary consultation on preferred product characteristics of benzathine penicillin G for secondary prophylaxis of rheumatic fever.

Authors:  Rosemary Wyber; Ben J Boyd; Samantha Colquhoun; Bart J Currie; Mark Engel; Joseph Kado; Ganesan Karthikeyan; Mark Sullivan; Anita Saxena; Meru Sheel; Andrew Steer; Joseph Mucumbitsi; Liesl Zühlke; Jonathan Carapetis
Journal:  Drug Deliv Transl Res       Date:  2016-10       Impact factor: 4.617

Review 5.  The Pan-African Society of Cardiology position paper on reproductive healthcare for women with rheumatic heart disease.

Authors:  Ana Olga Mocumbi; Keila K Jamal; Amam Mbakwem; Maylene Shung-King; Karen Sliwa
Journal:  Cardiovasc J Afr       Date:  2018-09-18       Impact factor: 0.802

Review 6.  Rheumatic heart disease screening: Current concepts and challenges.

Authors:  Scott Dougherty; Maziar Khorsandi; Philip Herbst
Journal:  Ann Pediatr Cardiol       Date:  2017 Jan-Apr

7.  Benzathine penicillin adherence for secondary prophylaxis among patients affected with rheumatic heart disease attending Mulago Hospital.

Authors:  Charles Musoke; Charles Kiiza Mondo; Emmy Okello; Wanzhu Zhang; Barbara Kakande; Wilson Nyakoojo; Juergen Freers
Journal:  Cardiovasc J Afr       Date:  2013-05       Impact factor: 1.167

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.